CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 2,410.00
-120.00 (-4.74%)
At close: Apr 2, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 112.23 billion as of April 2, 2026. Its market cap has increased by 26.22% in one year.
Market Cap
112.23B
Enterprise Value
142.99B
Revenue
20.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,410.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 112.23B, a decrease of -82.84%. That is a compound annual growth rate of -15.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 112.23B | 36.90% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 121.13B |
| KoBioLabs | 115.54B |
| NovMetaPharma | 112.88B |
| ViGenCell | 110.08B |
| Quratis | 102.92B |
| CHA Vaccine Research Institute | 100.34B |
| TegoScience | 100.16B |
| Cell Biotech | 95.81B |